Publications

Standardization of the liquid biopsy for pediatric diffuse midline glioma
Li, D, Bonner, ER, Wierzbicki, K, Panditharatna, E, Huang, T, Lulla, R, Mueller, S, Koschmann, C, Nazarian, J, Saratsis, AM, Sci Rep, 2021 Mar; DOI:10.1038/s41598-021-84513-1
PMID: 33658570
Colon cancer, Version 2.2021
Benson, AB, Venook, AP, Al-Hawary, MM, Arain, MA, Chen, Y-J, Ciombor, KK, Cohen, S, Cooper, HS, Deming, D, Farkas, L, Garrido-Laguna, I, Grem, JL, Gunn, A, Hecht, JR, Hoffe, S, Hubbard, J, Hunt, S, Johung, KL, Kirilcuk, N, Krishnamurthi, S, Messersmith, WA, Meyerhardt, J, Miller, ED, Mulcahy, MF, Nurkin, S, Overman, MJ, Parikh, A, Patel, H, Pedersen, K, Saltz, L, Schneider, C, Shibata, D, Skibber, JM, Sofocleous, CT, Stoffel, EM, Stotsky-Himelfarb, E, Willett, CG, Gregory, KM, Gurski, LA, J Natl Compr Canc Netw, 2021 Mar; DOI:10.6004/jnccn.2021.0012
PMID: 33724754
Optimization and evaluation of fluorescence in situ hybridization chain reaction in cleared fresh-frozen brain tissues.
Kumar, V, Krolewski, DM, Hebda-Bauer, EK, Parsegian, A, Martin, B, Foltz, M, Akil, H, Watson, SJ, Brain Struct Funct, 2021 Mar; DOI:10.1007/s00429-020-02194-4
PMID: 33386994
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach
Tosoian, JJ, Trock, BJ, Morgan, TM, Salami, SS, Tomlins, SA, Spratt, DE, Siddiqui, J, Kunju, LP, Botbyl, R, Chopra, Z, Pandian, B, Eyrich, NW, Longton, G, Zheng, Y, Palapattu, GS, Wei, JT, Niknafs, YS, Chinnaiyan, AM, J Urol, 2021 Mar; DOI:10.1097/JU.0000000000001430
PMID: 33080150
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
Brown, LC, Tucker, MD, Sedhom, R, Schwartz, EB, Zhu, J, Kao, C, Labriola, MK, Gupta, RT, Marin, D, Wu, Y, Gupta, S, Zhang, T, Harrison, MR, George, DJ, Alva, A, Antonarakis, ES, Armstrong, AJ, J Immunother Cancer, 2021 Mar; DOI:10.1136/jitc-2020-001792
PMID: 33653800
Association of anti-tumor necrosis factor therapy with mortality among veterans with inflammatory bowel disease
Cohen-Mekelburg, S, Wallace, BI, Van, T, Wiitala, WL, Govani, SM, Burns, J, Lipson, R, Yun, H, Hou, J, Lewis, JD, Dominitz, JA, Waljee, AK, JAMA Netw Open, 2021 Mar; DOI:10.1001/jamanetworkopen.2021.0313
PMID: 33646314
Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement Initiative.
Andino, JJ, Sessine, M, Singhal, U, Reichert, ZR, Wray, D, Shafer, C, Moore, M, Weizer, AZ, Kaffenberger, SD, Herrel, LA, Morgan, TM, Hafez, KZ, Montgomery, JS, Urol Pract, 2021 Mar; DOI:10.1097/UPJ.0000000000000200
PMID: 33655019
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
Ho, K, Fleseriu, M, Kaiser, U, Salvatori, R, Brue, T, Lopes, MB, Kunz, P, Molitch, M, Camper, SA, Gadelha, M, Syro, LV, Laws, E, Reincke, M, Nishioka, H, Grossman, A, Barkan, A, Casanueva, F, Wass, J, Mamelak, A, Katznelson, L, van der Lely, AJ, Radovick, S, Bidlingmaier, M, Boguszewski, M, Bollerslev, J, Hoffman, AR, Oyesiku, N, Raverot, G, Ben-Shlomo, A, Fowkes, R, Shimon, I, Fukuoka, H, Pereira, AM, Greenman, Y, Heaney, AP, Gurnell, M, Johannsson, G, Osamura, RY, Buchfelder, M, Zatelli, MC, Korbonits, M, Chanson, P, Biermasz, N, Clemmons, DR, Karavitaki, N, Bronstein, MD, Trainer, P, Melmed, S, J Endocr Soc, 2021 Mar; DOI:10.1210/jendso/bvaa205
PMID: 33604494
Immunotherapy for Merkel cell carcinoma
Angeles, CV, Sabel, MS, J Surg Oncol, 2021 Mar; DOI:10.1002/jso.26319
PMID: 33595894
Prediction of disease free survival in laryngeal and hypopharyngeal cancers using CT perfusion and radiomic features.
Woolen, S, Virkud, A, Hadjiiski, L, Cha, K, Chan, H-P, Swiecicki, P, Worden, F, Srinivasan, A, Tomography, 2021 Mar; DOI:10.3390/tomography7010002
PMID: 33681460
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
Han, J, Zhao, Y, Shirai, K, Molodtsov, A, Kolling, FW, Fisher, JL, Zhang, P, Yan, S, Searles, TG, Bader, JM, Gui, J, Cheng, C, Ernstoff, MS, Turk, MJ, Angeles, CV, Nat Cancer, 2021 Mar; DOI:10.1038/s43018-021-00180-1
PMID: 34179824
Physician leadership during the COVID-19 pandemic: an emphasis on the team, well-being and leadership reasoning.
Standiford, T, Davuluri, K, Trupiano, N, Portney, D, Gruppen, L, Vinson, AH, BMJ Leader, 2021 Mar;
PMID:
Assessment of task-based performance from five clinical DBT systems using an anthropomorphic breast phantom.
Ikejimba, LC, Salad, J, Graff, CG, Goodsitt, M, Chan, H-P, Huang, H, Zhao, W, Ghammraoui, B, Lo, JY, Glick, SJ, Med Phys, 2021 Mar; DOI:10.1002/mp.14568
PMID: 33128288
Abstract PO-086: Detection of cancer lesions in histopathological lung images using a sparse PCA network
Ram, S, Tang, W, Bell, AJ, Spencer, C, Buschhuas, A, Hatt, CR, di Magliano, MP, Galban, S, Galban, CJ, Clinical Cancer Research, 2021 Mar; DOI:10.1158/1557-3265.adi21-po-086
PMID:
Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors
Waninger, JJ, Ma, VT, Journey, S, Skvarce, J, Chopra, Z, Tezel, A, Bryant, AK, Mayo, C, Sun, Y, Sankar, K, Ramnath, N, Lao, C, Sussman, JB, Fecher, L, Alva, A, Green, MD, JAMA Netw Open, 2021 Mar; DOI:10.1001/jamanetworkopen.2021.0980
PMID: 33687443
Is Perineural Invasion a Reasonable Indicator for Neck Dissection in cT1N0M0 Squamous Cell Carcinoma of the Oral Cavity?
Alzahrani, S, Feng, Z, Cheng, A, Han, Z, Moe, J, Ward, BB, J Oral Maxillofac Surg, 2021 Mar; DOI:10.1016/j.joms.2020.08.038
PMID: 33010218
Which holds the key to BRCAness: Inability to repair the break, protect the fork, or prevent the gap?
Cancer Res, 2021 Mar; DOI:10.1158/0008-5472.CAN-20-4340
PMID: 33822743
Fiber density and matrix stiffness modulate distinct cell migration modes in a 3D stroma mimetic composite hydrogel
Hiraki, H, Matera, D, Wang, W, Zarouk, A, Argento, A, Buschhaus, J, Humphries, B, Luker, G, Baker, B, 2021 Feb; DOI:10.1101/2021.02.27.433190
PMID:
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
Pal, SK, Tangen, C, Thompson, IM, Balzer-Haas, N, George, DJ, Heng, DYC, Shuch, B, Stein, M, Tretiakova, M, Humphrey, P, Adeniran, A, Narayan, V, Bjarnason, GA, Vaishampayan, U, Alva, A, Zhang, T, Cole, S, Plets, M, Wright, J, Lara, PN, Lancet, 2021 Feb; DOI:10.1016/S0140-6736(21)00152-5
PMID: 33592176
Analysis of PFS2 by subsequent therapy in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as 1L therapy for advanced urothelial carcinoma (UC).
Ozguroglu, M, Alva, AS, Csőszi, T, Matsubara, N, Geczi, L, Cheng, SY, Fradet, Y, Oudard, S, Vulsteke, C, Morales-Barrera, R, Flechon, A, Gunduz, S, Loriot, Y, Rodriguez-Vida, A, Mamtani, R, Yu, EY, Nam, K, Imai, K, Homet Moreno, B, Powles, T, Journal of Clinical Oncology, 2021 Feb; DOI:10.1200/jco.2021.39.6_suppl.448
PMID:
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice
Kadiyala, P, Carney, SV, Gauss, JC, Garcia-Fabiani, MB, Haase, S, Alghamri, MS, Núñez, FJ, Liu, Y, Yu, M, Taher, A, Nunez, FM, Li, D, Edwards, MB, Kleer, CG, Appelman, H, Sun, Y, Zhao, L, Moon, JJ, Schwendeman, A, Lowenstein, PR, Castro, MG, J Clin Invest, 2021 Feb; DOI:10.1172/JCI139542
PMID: 33332283
Multi-institutional observer performance study for bladder cancer treatment response assessment in CT urography with and without computerized decision support
Hadjiiski, LM, Joshi, M, Alva, A, Chan, HP, Cohan, RH, Caoili, EM, Kirova-Nedyalkova, G, Davenport, MS, Shankar, PR, Francis, IS, Cha, KH, Samala, RK, Palmbos, PL, Weizer, AZ, Proc. SPIE Medical Imaging, 2021 Feb;
PMID:
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome
Abdulfatah, E, Reichert, ZR, Davenport, MS, Chinnaiyan, AM, Dadhania, V, Wang, X, Mannan, R, Kunju, LP, Hollenbeck, BK, Montgomery, JS, Kaffenberger, SD, Morgan, TM, Alva, AS, Palapattu, GS, Vaishampayan, UN, Alumkal, JJ, Spratt, DE, Udager, AM, Mehra, R, Med Oncol, 2021 Feb; DOI:10.1007/s12032-021-01473-2
PMID: 33586037
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes
Weiner, AB, Vidotto, T, Liu, Y, Mendes, AA, Salles, DC, Faisal, FA, Murali, S, McFarlane, M, Imada, EL, Zhao, X, Li, Z, Davicioni, E, Marchionni, L, Chinnaiyan, AM, Freedland, SJ, Spratt, DE, Wu, JD, Lotan, TL, Schaeffer, EM, Nat Commun, 2021 Feb; DOI:10.1038/s41467-021-21245-w
PMID: 33568675
Surveillance and Monitoring Techniques for HPV-Related Head and Neck Squamous Cell Carcinoma: Circulating Tumor DNA
Dermody, SM, Haring, CT, Bhambhani, C, Tewari, M, Brenner, JC, Swiecicki, PL, Curr Treat Options Oncol, 2021 Feb; DOI:10.1007/s11864-021-00821-8
PMID: 33559043